Emcure Pharmaceuticals Ltd
Healthcare
Bain-backed Emcure Pharma jumps 35% on listing at $223 mn valuation
Indian drugmaker Emcure Pharmaceuticals' shares rose 34.9% in debut trade on Wednesday, beating analysts' estimates and valuing the company at ......
Healthcare
Bain-backed Emcure Pharma attracts bids worth $11 bn in IPO
India's Emcure Pharmaceuticals drew strong interest for its $234 million initial public offering (IPO) as investors bet on its slate ......
Healthcare
Bain Capital stares at modest returns from another legacy India bet
Bain Capital, a bulge-bracket global private equity firm which has been on a harvest spree in India and signed off from two ......
Healthcare
Bain Capital tweaks exit plan from decade-old India portfolio company
American private equity firm Bain Capital, which has been particularly active in India this year having struck three new deals ......
Healthcare
Bain Capital-backed Emcure Pharma plans IPO, hires bankers
India's Emcure Pharmaceuticals aims to raise $400-$500 million from an initial public offering planned for next year, two sources said, ......
Healthcare
Company watch: Is Bain-backed Emcure on road to recovery after two years of pain?
In July 2015, the US health regulator banned imports from a Pune factory of Emcure Pharmaceuticals Ltd. The ban crimped ......
Healthcare
Eris Lifesciences acquires nutraceuticals maker UTH Healthcare
Drugmaker Eris Lifesciences Ltd has acquired nutraceuticals maker UTH Healthcare Ltd for Rs 12.85 crore ($1.96 million) in cash.Eris said ......
Healthcare
Company watch: Regulatory risks may weigh on Bain Capital-backed Emcure Pharma
India’s generics pharmaceutical industry has been hit over the past few years ever since the US Food and Drug Administration ......